These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32584154)

  • 1. Diagnostic accuracy of the repeatable battery of the assessment of neuropsychological status update, Spanish version, in predicting Alzheimer's disease among Hispanic older adults in the United States reporting memory problems.
    Barnes-Marrero I; Horter L; Hayden JD; Patel NC; Mendoza L; Castillo L
    Appl Neuropsychol Adult; 2022; 29(4):509-519. PubMed ID: 32584154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.
    Randolph C; Tierney MC; Mohr E; Chase TN
    J Clin Exp Neuropsychol; 1998 Jun; 20(3):310-9. PubMed ID: 9845158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Utility of the TYM and RBANS in a One-Stop Memory Clinic in Singapore: A Pilot Study.
    Dong Y; Ling MTY; Ng KET; Wang A; Wan EYS; Merchant RA; Venketasubramanian N; Chen CL; Mahendran R; Collinson SL
    J Geriatr Psychiatry Neurol; 2019 Mar; 32(2):68-73. PubMed ID: 30630388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer's disease.
    Karantzoulis S; Novitski J; Gold M; Randolph C
    Arch Clin Neuropsychol; 2013 Dec; 28(8):837-44. PubMed ID: 23867976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the RBANS in detecting cognitive impairment associated with Alzheimer's disease: sensitivity, specificity, and positive and negative predictive powers.
    Duff K; Humphreys Clark JD; O'Bryant SE; Mold JW; Schiffer RB; Sutker PB
    Arch Clin Neuropsychol; 2008 Sep; 23(5):603-12. PubMed ID: 18639437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Minimum Clinically Important Difference in the Repeatable Battery for the Assessment of Neuropsychological Status.
    Phillips R; Qi G; Collinson SL; Ling A; Feng L; Cheung YB; Ng TP
    Clin Neuropsychol; 2015; 29(7):905-23. PubMed ID: 26548428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting biomarkers in intact older adults and those with amnestic Mild Cognitive Impairment, and mild Alzheimer's Disease using the Repeatable Battery for the Assessment of Neuropsychological Status.
    Suhrie KR; Hammers DB; Porter SM; Dixon AM; King JB; Anderson JS; Duff K; Hoffman JM
    J Clin Exp Neuropsychol; 2021 Nov; 43(9):861-878. PubMed ID: 35019815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographically-adjusted normative data among Latinos for the version 3 of the Alzheimer's Disease Centers' Neuropsychological Test Battery in the Uniform Data Set.
    Marquine MJ; Parks A; Perales-Puchalt J; González DA; Rosado-Bruno M; North R; Pieper C; Werry AE; Kiselica A; Chapman S; Dodge H; Gauthreaux K; Kukull WA; Rascovsky K
    Alzheimers Dement; 2023 Sep; 19(9):4174-4186. PubMed ID: 37356069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Alzheimer's disease development: a comparison of cognitive criteria and associated neuroimaging biomarkers.
    Callahan BL; Ramirez J; Berezuk C; Duchesne S; Black SE;
    Alzheimers Res Ther; 2015 Nov; 7(1):68. PubMed ID: 26537709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between
    Hammers DB; Atkinson TJ; Dalley BC; Suhrie KR; Beardmore BE; Burrell LD; Horn KP; Rasmussen KM; Foster NL; Duff K; Hoffman JM
    Clin Neuropsychol; 2017 Apr; 31(3):531-543. PubMed ID: 28077020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of percent retention scores on RBANS verbal memory subtests for the diagnosis of Alzheimer's disease and mild cognitive impairment.
    Clark JH; Hobson VL; O'Bryant SE
    Arch Clin Neuropsychol; 2010 Jun; 25(4):318-26. PubMed ID: 20378680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spanish version of the Mattis Dementia Rating Scale-2 for early detection of Alzheimer's disease and mild cognitive impairment.
    Boycheva E; Contador I; Fernández-Calvo B; Ramos-Campos F; Puertas-Martín V; Villarejo-Galende A; Bermejo-Pareja F
    Int J Geriatr Psychiatry; 2018 Jun; 33(6):832-840. PubMed ID: 28332732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Japanese version of RBANS (Repeatable Battery for the Assessment of Neuropsychological Status)].
    Yamashima T; Yoshida M; Kumahashi K; Matsui M; Koshino Y; Higashima M; Nagasawa T; Ueki A; Ohtsuka M; Aoki S; Imuro S; Mori N; Takei N; Hoshino R; Minabe Y; Nanba Y; Nanba M; Kira J; Ohyagi Y; Haraoka J; Akimoto J; Miura N; Kimura S; Matsushita M
    No To Shinkei; 2002 Jun; 54(6):463-71. PubMed ID: 12166095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validity of the Japanese version of Rivermead Behavioural Memory Test for evaluation of everyday memory function in patients with mild Alzheimer's disease].
    Matsuda A; Kazui H; Hirono N; Mori E
    No To Shinkei; 2002 Aug; 54(8):673-8. PubMed ID: 12355878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial.
    Papp KV; Rofael H; Veroff AE; Donohue MC; Wang S; Randolph C; Grober E; Brashear HR; Novak G; Ernstrom K; Raman R; Aisen PS; Sperling R; Romano G; Henley D
    J Prev Alzheimers Dis; 2022; 9(2):255-261. PubMed ID: 35542998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the Spanish English Neuropsychological Assessment Scale in older adult Latines and those at risk for autosomal dominant Alzheimer's disease.
    Tureson KN; Beam CR; Medina LD; Segal-Gidan F; D'Orazio LM; Chui H; Torres M; Varma R; Ringman JM
    J Clin Exp Neuropsychol; 2023 Aug; 45(6):553-569. PubMed ID: 37990912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of depression and Alzheimer's disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R).
    Rotomskis A; Margevičiūtė R; Germanavičius A; Kaubrys G; Budrys V; Bagdonas A
    BMC Neurol; 2015 Apr; 15():57. PubMed ID: 25924912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
    Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
    Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.